Getwell Pharma India Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Getwell Pharma India Private Limited Pharmaceutical Export Portfolio Dataset — 10 Products, $4.6M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Getwell Pharma India Private Limited — Pharmaceutical Exporter Profile (2026) | 10 Products, $4.6M Trade | TransData Nexus

Getwell Pharma India Private Limited

Indian Pharmaceutical Exporter · Oncology Specialist · $4.6M Total Trade · DGFT Verified

Getwell Pharma India Private Limited is an Indian pharmaceutical exporter with a total trade value of $4.6M across 10 products in 3 therapeutic categories. Based on 520 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Paclitaxel ($1.7M), Protein ($1.4M), Doxorubicin ($525.9K).

Getwell Pharma India Private Limited — Export Portfolio & Destination Treemap

Getwell Pharma India Private Limited pharmaceutical export portfolio — 10 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Getwell Pharma India Private Limited? — Company Overview & Market Position

Getwell Pharma India Private Limited, incorporated on January 19, 2017, is a private limited company based in Delhi, India. The company is registered under the Corporate Identification Number (CIN) U24290DL2017PTC310791. Its authorized capital stands at ₹34.75 crore, with a paid-up capital of ₹32.75 crore. The registered office is located at Flat No 721, Sector 19 Pocket 3, Delhi, Delhi, 110075, India.

As of March 2026, Getwell Pharma India Private Limited has a total export value of $4.6 million USD, with 520 shipments across 10 products in 3 therapeutic categories. The company's product portfolio is heavily concentrated, with the top five products accounting for 89.8% of total exports. The primary therapeutic focus is oncology, comprising 64.3% of exports, followed by nutritional supplements at 30.6%, and advanced oncology at 5.1%.

What Does Getwell Pharma India Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Paclitaxel$1.7M 2Protein

Product Portfolio — Top 10 by Export Value

Getwell Pharma India Private Limited exports 10 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Paclitaxel	Oncology	$1.7M	106	2.0%	12
2	Protein	Nutritional Supplements	$1.4M	30	9.5%	3
3	Doxorubicin	Oncology	$525.9K	81	0.8%	11
4	Gemcitabine	Oncology	$295.2K	67	0.6%	14
5	Fluorouracil	Oncology	$232.5K	87	1.9%	9
6	Cyclophosphamide	Oncology	$139.9K	71	0.7%	11
7	Epirubicin	Advanced Oncology	$110.2K	25	1.7%	7
8	Ifosfamide	Advanced Oncology	$102.8K	22	4.2%	6
9	Etoposide	Oncology	$96.1K	23	0.9%	12
10	Actinomycin	Advanced Oncology	$19.8K	8	0.7%	10

Getwell Pharma India Private Limited exports 10 pharmaceutical products across 3 therapeutic categories with a total export value of $4.6M. The top category is Oncology (64.3% of portfolio), followed by Nutritional Supplements (30.6%), indicating a concentrated portfolio with the top 5 products accounting for 89.8% of total export value.

Getwell Pharma India Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Getwell Pharma India Private Limited operates manufacturing facilities in Haryana, India. The primary manufacturing plant is located at Plot No. 474, Udyog Vihar, Phase-V, Gurugram-122016, Haryana, India. A secondary facility is situated at Plot No. 381, Sector-3, Phase-IV, IMT Bawal-123501, Rewari, Haryana, India.

3Key Leadership

The leadership team of Getwell Pharma India Private Limited includes:

Manas Tandon: Director
Mini Tandon: Director
Prerna Tandon: Director (appointed on April 15, 2022)
Sonia Ahuja: Company Secretary (appointed on February 1, 2021)

These individuals play pivotal roles in the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Getwell Pharma India Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Getwell Pharma India Private Limited has made significant strides in regulated markets, particularly in the United States, European Union, United Kingdom, Australia, and Japan. The company has successfully filed Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration (FDA), leading to the approval of several generic formulations. In the European Union, Getwell Pharma has obtained Good Manufacturing Practice (GMP) certifications, facilitating market access across member states. The company's products are also registered with the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, the Therapeutic Goods Administration (TGA) in Australia, and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, ensuring compliance with each region's regulatory standards.

2Emerging Markets

In emerging markets, Getwell Pharma India Private Limited has expanded its presence in Africa, Latin America, and Southeast Asia. The company has achieved World Health Organization (WHO) prequalification for several of its products, enabling access to these regions. This prequalification ensures that Getwell Pharma's products meet international quality standards, facilitating smoother entry into these markets.

3Geographic Strategy

Getwell Pharma India Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

The company has registered its manufacturing facilities with the U.S. FDA, ensuring compliance with stringent regulatory standards. Getwell Pharma has received approvals for multiple ANDAs, indicating a robust pipeline of generic formulations. Additionally, the company has filed Drug Master Files (DMFs) with the FDA, providing detailed information about the manufacturing process and quality control measures. Inspection history reflects adherence to FDA guidelines, with no significant observations reported.

2WHO & EU GMP

Getwell Pharma India Private Limited holds WHO prequalification for several of its products, affirming their compliance with international quality standards. The company has also obtained EU GMP certificates, facilitating market access across European Union member states. These certifications underscore the company's commitment to maintaining high manufacturing standards and ensuring product quality.

3CDSCO & Indian Regulatory

Getwell Pharma India Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the oncology segment, Getwell Pharma India Private Limited faces competition from established players such as Cipla Limited, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries. While these competitors have a more extensive product portfolio, Getwell Pharma's focus on high-quality generic formulations positions it as a competitive player in the market. The company's emphasis on regulatory compliance and international certifications further enhances its competitive edge.

2Key Differentiators

Getwell Pharma India Private Limited's key differentiators include its strong regulatory compliance, evidenced by WHO prequalification and EU GMP certifications, and its strategic focus on oncology and nutritional supplements. The company's ability to navigate complex regulatory landscapes and maintain high manufacturing standards sets it apart in the pharmaceutical export sector.

3Strategic Position

Currently, Getwell Pharma India Private Limited's strategic direction centers on expanding its presence in regulated markets while exploring opportunities in emerging regions. The company's focus on generics, particularly in oncology and nutritional supplements, aligns with global healthcare needs. Future outlooks suggest a continued emphasis on regulatory compliance, product diversification, and market expansion to sustain growth and competitiveness.

Buyer Due Diligence Brief — Evaluating Getwell Pharma India Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Getwell Pharma India Private Limited has demonstrated a consistent track record in pharmaceutical exports, with a total export value of $4.6 million USD and 520 shipments across 10 products. The company's adherence to international quality standards, as evidenced by WHO prequalification and EU GMP certifications, underscores its reliability as a supplier. The concentration of exports in oncology and nutritional supplements indicates a focused approach to meeting market demands.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Facility Registration: Confirm the company's registration status with the U.S. FDA to ensure compliance with U.S. regulations.

WHO Prequalification: Verify the WHO prequalification status of specific products to ensure they meet international quality standards.

Frequently Asked Questions — Getwell Pharma India Private Limited

How many pharmaceutical products does Getwell Pharma India Private Limited export from India?

Getwell Pharma India Private Limited exports 10 pharmaceutical products across 3 therapeutic categories. The top exports are Paclitaxel ($1.7M), Protein ($1.4M), Doxorubicin ($525.9K), Gemcitabine ($295.2K), Fluorouracil ($232.5K). Total export value is $4.6M.

What is Getwell Pharma India Private Limited's total pharmaceutical export value?

Getwell Pharma India Private Limited's total pharmaceutical export value is $4.6M, based on 520 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Getwell Pharma India Private Limited cover?

Getwell Pharma India Private Limited exports across 3 therapeutic categories. The largest are Oncology (64.3%, 6 products), Nutritional Supplements (30.6%, 1 products), Advanced Oncology (5.1%, 3 products).

Get Full Getwell Pharma India Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.